Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Healthcare Medical Devices
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Recent & Breaking News (NDAQ:PLSE)

Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer

Business Wire February 15, 2022

PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm

Business Wire February 13, 2022

PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm

Business Wire February 11, 2022

The Law Offices of Frank R. Cruz Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

Business Wire February 11, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pulse Biosciences, Inc. - PLSE

Newsfile February 10, 2022

Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation

Business Wire February 10, 2022

Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation

Business Wire February 9, 2022

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors

Business Wire February 8, 2022

SHAREHOLDER ALERT: Investigation of Pulse Biosciences, Inc. (PLSE) Announced by Holzer & Holzer, LLC

Newsfile February 8, 2022

Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission

Business Wire February 8, 2022

Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Business Wire February 1, 2022

Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results

Business Wire January 11, 2022

Pulse Biosciences to Participate in the Stephens Annual Investment Conference

Business Wire November 18, 2021

Pulse Biosciences Reports Third Quarter 2021 Financial Results

Business Wire November 15, 2021

Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference

Business Wire November 4, 2021

Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021

Business Wire November 2, 2021

Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors

Business Wire October 5, 2021

Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference

Business Wire September 2, 2021

Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer

Business Wire August 19, 2021

Pulse Biosciences Reports Second Quarter 2021 Financial Results

Business Wire August 9, 2021